Neuronetics promotes Cory Anderson to EVP, General Manager of Greenbrook

Neuronetics, Inc.

Cory Anderson promoted from SVP, CTO to EVP, General Manager of Greenbrook effective July 1, 2026.
New annual base salary of $425,000; target annual bonus increased to 45% of base salary.
Anderson has over 25 years of medical device experience, previously SVP R&D and Clinical since Jan 2025.
Holds B.S./M.S. in Biomedical Engineering from Tulane and MBA from Emory University.
No family relationships or related party transactions with the company's directors or officers.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Cory Anderson

Executive Vice President, General Manager of Greenbrook

STIM · Neuronetics, Inc.

Effective: 2026-07-01
Filed: June 23, 2026, 4:38 PM ET

On June 16, 2026, the board of directors of the Company (the “Board”) promoted Cory Anderson from the position of Senior Vice President, Chief Technology Officer to the position of Executive Vice President, General Manager of Greenbrook effective July 1, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Cory Anderson changed role as Executive Vice President, General Manager of Greenbrook at Neuronetics, Inc..

Action: promoted
Role: Executive Vice President, General Manager of Greenbrook

Exact text from the filing

On June 16, 2026, the board of directors of the Company (the “Board”) promoted Cory Anderson from the position of Senior Vice President, Chief Technology Officer to the position of Executive Vice President, General Manager of Greenbrook effective July 1, 2026.

View on SEC.gov

Neuronetics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-279601

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.